Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977621 | 12597762 | 1 | I | 201509 | 20160719 | 20160727 | 20160727 | PER | US-PFIZER INC-2016352161 | PFIZER | 80.00 | YR | F | Y | 85.00000 | KG | 20160727 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977621 | 12597762 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | 20 MG, UNK | 20702 | 20 | MG | FILM-COATED TABLET | ||||||||
| 125977621 | 12597762 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY ONE IN THE MORNING | 20702 | 10 | MG | FILM-COATED TABLET | QD | ||||||
| 125977621 | 12597762 | 3 | C | ZIAC | BISOPROLOL FUMARATEHYDROCHLOROTHIAZIDE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 125977621 | 12597762 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | 5 MG, UNK | 0 | 5 | MG | |||||||||
| 125977621 | 12597762 | 5 | C | LOTENSIN | BENAZEPRIL HYDROCHLORIDE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 125977621 | 12597762 | 6 | C | LOSARTAN. | LOSARTAN | 1 | 50 MG, 1X/DAY | 0 | 50 | MG | QD | ||||||||
| 125977621 | 12597762 | 7 | C | LASIX | FUROSEMIDE | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | QD | ||||||||
| 125977621 | 12597762 | 8 | C | MAGNESIUM | MAGNESIUM | 1 | 400 MG, 2X/DAY | 0 | 400 | MG | BID | ||||||||
| 125977621 | 12597762 | 9 | C | HUMALOG | INSULIN LISPRO | 1 | 38 UNITS IN THE MORNING AND 37 IN THE AFTERNOON | 0 | 75 | IU | |||||||||
| 125977621 | 12597762 | 10 | C | VITAMIN B1 | THIAMINE HYDROCHLORIDE | 1 | 100 MG, 1X/DAY | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125977621 | 12597762 | 1 | Blood cholesterol |
| 125977621 | 12597762 | 3 | Blood pressure measurement |
| 125977621 | 12597762 | 4 | Blood pressure measurement |
| 125977621 | 12597762 | 5 | Blood pressure measurement |
| 125977621 | 12597762 | 6 | Blood pressure measurement |
| 125977621 | 12597762 | 7 | Diuretic therapy |
| 125977621 | 12597762 | 8 | Blood magnesium decreased |
| 125977621 | 12597762 | 9 | Diabetes mellitus |
| 125977621 | 12597762 | 10 | Neuralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125977621 | 12597762 | Gait disturbance | |
| 125977621 | 12597762 | Joint stiffness | |
| 125977621 | 12597762 | Musculoskeletal stiffness | |
| 125977621 | 12597762 | Pain in extremity | |
| 125977621 | 12597762 | Peripheral swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |